CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer

E-ISSN： 2045-7634|4|9|1322-1333

ISSN： 2045-7634

Source： Cancer Medicine, Vol.4, Iss.9, 2015-09, pp. : 1322-1333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sex as a Prognostic Factor in Gastric Cancer

By Maguire A. Porta M. Sanz-Anquela J.M. Ruano I. Malats N. Pinol J.L.

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1303-1309

Elsevier

Access to resources Recommend Favorite

The role of p53 mutations as a prognostic factor and therapeutic target in inflammatory breast cancer

By Yang Charles H Cristofanilli Massimo

Future Oncology, Vol. 2, Iss. 2, 2006-04 ,pp. : 247-255

Future Medicine

Access to resources Recommend Favorite

Tumor Diameter as a Prognostic Factor in Patients with Gastric Cancer

By Kunisaki Chikara

Annals of Surgical Oncology, Vol. 15, Iss. 7, 2008-07 ,pp. : 1959-1967

Springer Publishing Company

Access to resources Recommend Favorite

The lymph node ratio as a prognostic factor for gastric cancer

By Nelen Stijn D. van Steenbergen Liza N. Dassen Anneriet E. van der Wurff Anneke A.M. Lemmens Valery E.P.P. Bosscha Koop

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1751-1759

Informa Healthcare

Access to resources Recommend Favorite

Breast Cancer Angiogenesis: Therapy Target and Prognostic Factor

By Harris A.L. Fox S. Leek R. Zhang H. Scott P. Bicknell R. Gatter K.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 831-832

Elsevier

Access to resources Recommend Favorite